
IndraLab
Statements
5-aza-2'-deoxycytidine inhibits NFKBIA. 3 / 3
|
3
reach
"In conclusion, our study demonstrates that low-dose decitabine induces degradation of IkappaBalpha by beta-TrCP through a proteasome degradation pathway, to boost NF-kappaB activation and thus promotes the proliferation of IFN-gamma + CD4 + T cells and enhances the anti-tumor immune activity of CD4 + T cells (XREF_FIG)."